The National Institutes of Health (NIH) is offering this multi-project research grant to advance cell and gene therapies aimed at achieving long-term remission or elimination of HIV. This grant is for supporting comprehensive programs that encompass basic science discovery and preclinical research, including test-of-concept studies in animal models. The ultimate goal is to develop approaches that can be eventually evaluated in clinical settings, scaled up, and delivered efficiently. Applicants are required to collaborate with one or more private sector partners to ensure translational impact and facilitate the pipeline development of these innovative therapies.
Opportunity ID: 353440
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-24-013 |
| Funding Opportunity Title: | Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.233 — National Center on Sleep Disorders Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 08, 2024 |
| Last Updated Date: | Apr 08, 2024 |
| Original Closing Date for Applications: | Jul 30, 2024 |
| Current Closing Date for Applications: | Jul 30, 2024 |
| Archive Date: | Sep 04, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Public housing authorities/Indian housing authorities Private institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Native American tribal governments (Federally recognized) Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Notice of Funding Opportunity (NOFO) is to support multi-project research programs for the development, characterization, and advancement of gene- and cell-based approaches to achieve long-term remission or elimination of HIV. Approaches will eventually be evaluated in the clinic, rendered scalable and deliverable. Applications are expected to include basic science discovery as well as preclinical research activities such as test-of-concept studies in animal models. Applicants are required to include one or more private sector partner to participate in their program. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-013.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 353440 Full Announcement-RFA-AI-24-013 -> RFA-AI-24-013-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00285777 | Jun 30, 2024 | Jul 30, 2024 | View |
Package 1
Mandatory forms
353440 RR_SF424_5_0-5.0.pdf
353440 PHS398_CoverPageSupplement_5_0-5.0.pdf
353440 RR_OtherProjectInfo_1_4-1.4.pdf
353440 PerformanceSite_4_0-4.0.pdf
353440 RR_KeyPersonExpanded_4_0-4.0.pdf
353440 PHS398_ResearchPlan_5_0-5.0.pdf
353440 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
353440 PHS_Additional_IndirectCosts_2_0-2.0.pdf
353440 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
